sGSK Group, A-Star Neuroscience Research Partnership, Proteos Building, 61 Biopolis Drive, Singapore 138673, Singapore.
Biochem J. 2011 Apr 15;435(2):355-64. doi: 10.1042/BJ20102156.
The non-RTK (receptor tyrosine kinase) ACK1 [activated Cdc42 (cell division cycle 42)-associated kinase 1] binds a number of RTKs and is associated with their endocytosis and turnover. Its mode of activation is not well established, but models have suggested that this is an autoinhibited kinase. Point mutations in its SH3 (Src homology 3)- or EGF (epidermal growth factor)-binding domains have been reported to activate ACK1, but we find neither of the corresponding W424K or F820A mutations do so. Indeed, deletion of the various ACK1 domains C-terminal to the catalytic domain are not associated with increased activity. A previous report identified only one major tyrosine phosphorylated protein of 60 kDa co-purified with ACK1. In a screen for new SH3 partners for ACK1 we found multiple Src family kinases; of these c-Src itself binds best. The SH2 and SH3 domains of Src interact with ACK1 Tyr518 and residues 623-652 respectively. Src targets the ACK1 activation loop Tyr284, a poor autophosphorylation site. We propose that ACK1 fails to undergo significant autophosphorylation on Tyr284 in vivo because it is basophilic (whereas Src is acidophilic). Subsequent ACK1 activation downstream of receptors such as EGFR (EGF receptor) (and Src) promotes turnover of ACK1 in vivo, which is blocked by Src inhibitors, and is compromised in the Src-deficient SYF cell line. The results of the present study can explain why ACK1 is responsive to so many external stimuli including RTKs and integrin ligation, since Src kinases are commonly recruited by multiple receptor systems.
非受体酪氨酸激酶(RTK)ACK1[激活 Cdc42(细胞分裂周期 42)相关激酶 1]与许多 RTKs 结合,并与它们的内吞作用和周转有关。其激活方式尚未得到很好的确定,但模型表明这是一种自抑制激酶。已经报道了其 SH3(Src 同源 3)或 EGF(表皮生长因子)结合结构域中的点突变会激活 ACK1,但我们发现相应的 W424K 或 F820A 突变均不会激活 ACK1。实际上,删除催化结构域之后的 ACK1 结构域均与活性增加无关。以前的报告仅鉴定了与 ACK1 共纯化的一种主要的 60 kDa 酪氨酸磷酸化蛋白。在筛选 ACK1 的新 SH3 伴侣时,我们发现了多种 Src 家族激酶;其中 c-Src 本身结合最好。Src 的 SH2 和 SH3 结构域分别与 ACK1 Tyr518 和残基 623-652 相互作用。Src 将 ACK1 激活环 Tyr284 作为靶标,这是一个较差的自身磷酸化位点。我们提出,ACK1 在体内不会因碱性(而 Src 是酸性)而在 Tyr284 上发生明显的自身磷酸化。随后,EGFR(EGF 受体)(和 Src)等受体下游的 ACK1 激活会促进体内 ACK1 的周转,该过程被 Src 抑制剂阻断,并且在 Src 缺陷的 SYF 细胞系中受到损害。本研究的结果可以解释为什么 ACK1 对包括 RTK 和整合素连接在内的如此多的外部刺激有反应,因为 Src 激酶通常被多种受体系统募集。